Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Cypress, California 90630


Purpose:

The hypothesis of this study is that subcutaneous administration of tanezumab results in lower drug exposure compared to intravenous administration of tanezumab.


Criteria:

Inclusion Criteria: - Generally healthy - BMI of 18-30 kg/m2 - more than 50 kg bodyweight. Exclusion Criteria: - Pregnant - exposure to biologic type drugs within the last 3 months - history of allergic or anaphylactic reaction to a biologic drug - use of tobacco- or nicotine containing products that is more than what is in 5 cigarettes per day - excessive alcohol use.


NCT ID:

NCT00788294


Primary Contact:

Study Director
Pfizer CT.gov Call Center
Pfizer


Backup Contact:

N/A


Location Contact:

Cypress, California 90630
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.